Effect of HIFU on endometrial receptivity and sex hormone level in uterine fibroid patients and analysis of influencing factors for its treatment rate

被引:11
作者
Cui, Yongmei [1 ]
Dong, Yanyan [2 ]
Guo, Bingcheng [3 ]
Xing, Cuihong [4 ]
Gao, Xiaohui [4 ]
Su, Dexing [5 ]
机构
[1] Jining Maternal & Child Hlth Family Planning Serv, Dept Ultrasonog, Jining 272000, Shandong, Peoples R China
[2] Jiaxiang Peoples Hosp, Dept Ultrasonog, Jining 272400, Shandong, Peoples R China
[3] Jining 1 Peoples Hosp, Dept Ultrasonog, 6 Jiankang Rd, Jining 272011, Shandong, Peoples R China
[4] Zhangqiu Peoples Hosp, Dept Internal Med Ward, Jinan 250200, Shandong, Peoples R China
[5] Zhangqiu Peoples Hosp, Dept Cardiol, Jinan 250200, Shandong, Peoples R China
关键词
high intensity focused ultrasound; uterine fibroid; endometrial receptivity; sex hormone level; treatment rate; influencing factor; INTENSITY FOCUSED ULTRASOUND; ABLATION; MANAGEMENT;
D O I
10.3892/etm.2019.7194
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Effect of high intensity focused ultrasound (HIFU) uterine fibroid ablation on the endometrial receptivity and sex hormone level in uterine fibroid patients and the influencing factors for treatment rate were investigated. A retrospective analysis of 266 uterine fibroid patients admitted to the Department of Gynaecology in the Jining Maternity and Child Care Hospital from October 2013 to October 2016 was performed. Among them, observation group was treated with HIFU ablation (n=143), control group with myomectomy (n=123). The pulsatility index (PI) and the resistance index (RI) of the uterine arterial blood flow were measured during the luteal phase of menstruation by transvaginal ultrasonography. The serum luteinizing hormone (LH), follicle stimulating hormone (FSH) and estradiol (E-2) were detected by chemical immunofluorescence. The relationship between HIFU treatment rate and clinical pathology of uterine fibroid patients was analyzed, and univariate/multivariate regression analysis was used to analyze the influencing factors for HIFU treatment rate. There was no significant difference in preoperative and postoperative PI and RI between the two groups (P>0.05); no significant difference between preoperative and postoperative PI/RI in the same group (P>0.05). There was no significant difference in preoperative and postoperative LH, FSH and E-2 between the two groups (P>0.05); no significant difference between preoperative LH and postoperative LH in the same group (P>0.05), neither FSH or E-2 (P>0.05). Results of multivariate analysis showed that fibroid location and ultrasound contrast intensity were independent influencing factors for HIFU treatment rate (P<0.05). Treatment of uterine fibroid with HIFU has no effect on the patient's endometrial receptivity and sex hormone level. Fibroid location and ultrasound contrast intensity are independent risk factors for HIFU treatment rate. This study provides guidance for the clinical optimization of treatment methods and is more conducive to the promotion of HIFU ablation therapy.
引用
收藏
页码:2291 / 2297
页数:7
相关论文
共 24 条
[1]  
BOURDET AT, 2015, INT J WOMENS HLTH, V7, P321, DOI DOI 10.2147/IJWH.S50016
[2]   EFFECT OF BLOOD PERFUSION ON THE ABLATION OF LIVER PARENCHYMA WITH HIGH-INTENSITY FOCUSED ULTRASOUND [J].
CHEN, L ;
TERHAAR, G ;
HILL, CR ;
DWORKIN, M ;
CARNOCHAN, P ;
YOUNG, H ;
BENSTED, JPM .
PHYSICS IN MEDICINE AND BIOLOGY, 1993, 38 (11) :1661-1673
[3]   Alcohol consumption and risk of uterine myoma: A systematic review and meta analysis [J].
Chiaffarino, Francesca ;
Cipriani, Sonia ;
Ricci, Elena ;
La Vecchia, Carlo ;
Chiantera, Vito ;
Bulfoni, Alessandro ;
Parazzini, Fabio .
PLOS ONE, 2017, 12 (11)
[4]   Role of vaginal sonography and hysterosonography in the endoscopic treatment of uterine myomas [J].
Cohen, LS ;
Valle, RF .
FERTILITY AND STERILITY, 2000, 73 (02) :197-204
[5]   Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review [J].
Daher, Saleh ;
Massarwa, Muhammad ;
Benson, Ariel A. ;
Khoury, Tawfik .
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2018, 6 (01) :69-78
[6]   Emerging treatment options for uterine fibroids [J].
Donnez, Jacques ;
Arriagada, Pablo ;
Donnez, Olivier ;
Dolmans, Marie-Madeleine .
EXPERT OPINION ON EMERGING DRUGS, 2018, 23 (01) :17-23
[7]   Uterine fibroid management: from the present to the future [J].
Donnez, Jacques ;
Dolmans, Marie-Madeleine .
HUMAN REPRODUCTION UPDATE, 2016, 22 (06) :665-686
[8]   High intensity focused ultrasound: The fundamentals, clinical applications and research trends [J].
Elhelf, I. A. Shehata ;
Albahar, H. ;
Shah, U. ;
Oto, A. ;
Cressman, E. ;
Almekkawy, M. .
DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2018, 99 (06) :349-359
[9]   Application of dexmedetomidine-remifentanil in high-intensity ultrasound ablation of uterine fibroids: a randomised study [J].
Fu, X. ;
Huang, F. ;
Chen, Y. ;
Deng, Y. ;
Wang, Z. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 :23-29
[10]  
Ghobrial FEI, 2017, POL J RADIOL, V82, P593, DOI 10.12659/PJR.902930